Yes, Eroxon® has been certified (under EU Regulation 2017/745 – the “MDR”) as a Class 2 medical device, intended to be used for the treatment of erectile dysfunction. As a CE-marked medical device, it meets the safety, health and environmental protection requirements of the EU, including clinically proven efficacy. Eroxon® may be marketed throughout Europe. It is also approved in the UK as a Class 2 medical device with a UKCA mark.
The information on this site is intended for consumers and healthcare professionals in the European Economic Area or the United Kingdom. Eroxon is not available in jurisdictions outside the European Economic Area or the United Kingdom. Users outside these jurisdictions,
please click here.